4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Engineering and functional characterization of a proton-driven β-lactam antibiotic translocation module for bionanotechnological applications

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Novel approaches in synthetic biology focus on the bottom-up modular assembly of natural, modified natural or artificial components into molecular systems with functionalities not found in nature. A possible application for such techniques is the bioremediation of natural water sources contaminated with small organic molecules (e.g., drugs and pesticides). A simple molecular system to actively accumulate and degrade pollutants could be a bionanoreactor composed of a liposome or polymersome scaffold combined with energizing- (e.g., light-driven proton pump), transporting- (e.g., proton-driven transporter) and degrading modules (e.g., enzyme). This work focuses on the engineering of a transport module specific for β-lactam antibiotics. We previously solved the crystal structure of a bacterial peptide transporter, which allowed us to improve the affinity for certain β-lactam antibiotics using structure-based mutagenesis combined with a bacterial uptake assay. We were able to identify specific mutations, which enhanced the affinity of the transporter for antibiotics containing certain structural features. Screening of potential compounds allowed for the identification of a β-lactam antibiotic ligand with relatively high affinity. Transport of antibiotics was evaluated using a solid-supported membrane electrophysiology assay. In summary, we have engineered a proton-driven β-lactam antibiotic translocation module, contributing to the growing toolset for bionanotechnological applications.

          Related collections

          Most cited references38

          • Record: found
          • Abstract: found
          • Article: not found

          Synthetic biology

          Key Points Synthetic biology is a growing discipline that has two subfields. One uses unnatural molecules to reproduce emergent behaviors from natural biology, with the goal of creating artificial life. The other seeks interchangeable parts from natural biology to assemble into systems that act unnaturally. Either way, a synthetic goal forces scientists to cross uncharted ground to encounter and solve problems that are not easily encountered through analytical methods. This drives the emergence of new paradigms in ways that analysis cannot easily do. The common goal for both subfields is the use of interchangeable parts to develop new systems to meet performance specifications. These parts must function (to a first approximation) independently. Obtaining interchangeable parts is easier in the macroscopic world than in the molecular world; the principal challenge in synthetic biology is to identify interchangeable parts in the molecular world. The development of living chemical systems and novel organisms allows the scientific community to better understand how the individual chemicals and genes involved in biology interact to form new emergent properties. Synthetic biologists have developed artificial genetic systems that can undergo Darwinian evolution. This has provided insight into the chemical constraints that need to be met by a genetic system. Synthetic biologists have also developed 'toy' organisms and systems, such as an organism that functions as an oscillation system, and a molecular automaton that can interactively play tic-tac-toe with a human. Synthetic biology has used metabolic-pathway design and genetic elements to develop organisms that can synthesize important chemicals, such as precursors for antibiotics and polymers. Truly interchangeable parts at the molecular level have so far only been obtained with nucleic acids. Using amino acids and the secondary structural elements of proteins as interchangeable parts has not yet been possible. Interchangeable genetic elements are possible, although their use is not without complications. Artificial chemical systems that support Darwinian evolution — the bridge between non-life and life — are allowing synthetic biologists to realize the relationship between life and chemistry. The hazards of synthetic biology are open for discussion, because the ability to develop living systems and organisms with novel functions could conceivably be used maliciously.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The major facilitator superfamily (MFS) revisited.

            The major facilitator superfamily (MFS) is the largest known superfamily of secondary carriers found in the biosphere. It is ubiquitously distributed throughout virtually all currently recognized organismal phyla. This superfamily currently (2012) consists of 74 families, each of which is usually concerned with the transport of a certain type of substrate. Many of these families, defined phylogenetically, do not include even a single member that is functionally characterized. In this article, we probe the evolutionary origins of these transporters, providing evidence that they arose from a single 2-transmembrane segment (TMS) hairpin structure that triplicated to give a 6-TMS unit that duplicated to a 12-TMS protein, the most frequent topological type of these permeases. We globally examine MFS protein topologies, focusing on exceptional proteins that deviate from the norm. Nine distantly related families appear to have members with 14 TMSs in which the extra two are usually centrally localized between the two 6-TMS repeat units. They probably have arisen by intragenic duplication of an adjacent hairpin. This alternative topology probably arose multiple times during MFS evolution. Convincing evidence for MFS permeases with fewer than 12 TMSs was not forthcoming, leading to the suggestion that all 12 TMSs are required for optimal function. Some homologs appear to have 13, 14, 15 or 16 TMSs, and the probable locations of the extra TMSs were identified. A few MFS permeases are fused to other functional domains or are fully duplicated to give 24-TMS proteins with dual functions. Finally, the MFS families with no known function were subjected to genomic context analyses leading to functional predictions. © 2012 The Authors Journal compilation © 2012 FEBS.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Insertions and Duplications in the Polyproline Region of the Hepatitis E Virus

              Recombinant strains of hepatitis E virus (HEV) with insertions of human genomic fragments or HEV sequence duplications in the sequence encoding the polyproline region (PPR) were previously described in chronically infected patients. Such genomic rearrangements confer a replicative advantage in vitro but little is known about their frequency, location, or origin. As the sequences of only a few virus genomes are available, we analyzed the complete genomes of 114 HEV genotype 3 strains from immunocompromised (n = 85) and immunocompetent (n = 29) patients using the single molecular real-time sequencing method to determine the frequency, location, and origin of inserted genomic fragments, plus the proportions of variants with genomic rearrangements in each virus quasispecies. We also examined the amino acid compositions and post-translational modifications conferred by these rearrangements by comparing them to sequences without human gene insertions or HEV gene duplications. We found genomic rearrangements in 7/114 (6.1%) complete genome sequences (4 HEV-3f, 1 HEV-3e, 1 HEV-3 h, and 1 HEV-3chi-new), all from immunocompromised patients, and 3/7 were found at the acute phase of infection. Six of the seven patients harbored virus-host recombinant variants, including one patient with two different recombinant variants. We also detected three recombinant variants with genome duplications of the PPR or PPR + X domains in a single patient. All the genomic rearrangements (seven human fragment insertions of varying origins and three HEV genome duplications) occurred in the PPR. The sequences with genomic rearrangements had specific characteristics: increased net load (p < 0.001) and more ubiquitination (p < 0.001), phosphorylation (p < 0.001), and acetylation (p < 0.001) sites. The human fragment insertions and HEV genome duplications had slightly different characteristics. We believe this is the first description of HEV strains with genomic rearrangements in patients at the acute phase of infection; perhaps these strains are directly transmitted. Clearly, genomic rearrangements produce a greater net load with duplications and insertions having different features. Further studies are needed to clarify the mechanisms by which such modifications influence HEV replication.
                Bookmark

                Author and article information

                Contributors
                dimitrios.fotiadis@ibmm.unibe.ch
                Journal
                Sci Rep
                Sci Rep
                Scientific Reports
                Nature Publishing Group UK (London )
                2045-2322
                26 August 2021
                26 August 2021
                2021
                : 11
                : 17205
                Affiliations
                GRID grid.5734.5, ISNI 0000 0001 0726 5157, Institute of Biochemistry and Molecular Medicine, , University of Bern, ; 3012 Bern, Switzerland
                Article
                96298
                10.1038/s41598-021-96298-4
                8390754
                34446740
                68d2d4a6-5bd2-4c48-8d7e-5f92a754cff3
                © The Author(s) 2021

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 1 May 2021
                : 23 July 2021
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100001711, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung;
                Award ID: 310030_184980
                Award Recipient :
                Funded by: NCCR Molecular Systems Engineering
                Funded by: FundRef http://dx.doi.org/10.13039/100009068, Universität Bern;
                Categories
                Article
                Custom metadata
                © The Author(s) 2021

                Uncategorized
                membrane proteins,permeation and transport,membrane structure and assembly,structural biology

                Comments

                Comment on this article